ClinicalTrials.gov
public full text
Public Domain
Use of Infliximab for the Treatment of Pemphigus Vulgaris
Pemphigus vulgaris (PV) is a rare skin disorder that causes blistering of the skin and mucous membranes. Infliximab is a man-made antibody used to treat certain types of immune system disorders, including rheumatoid arthritis and Crohn's disease. This study will determine if infliximab given in combination with prednisone is a safe and effective treatment for adults with PV.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Cantharidin in Molluscum Contagiosum#824815
- Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis#858991
- Low Dose Cyclophosphamide Treats Genital Warts#1044725
- Determination of Blomia Tropicalis Allergen Extract in Prick Test Units#1008857
- Verifikasi Metode ELISA (Enzym Linked Immunosorbent Assay) Untuk Penentuan Kadar AMH (Anti Mullerian Hormone): Verification of The ELISA Method (Enzym Linked Immunosorbent Assay) for Determination of AMH Levels (Anti Mullerian Hormone)#1003739
Record · ID 848945
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive